|Articles|January 1, 2013
- Pharmaceutical Executive-01-01-2013
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - January 2013
Industry Forecast 2013, The Search for Safe Harbors
Advertisement
Articles in this issue
over 13 years ago
Industry Forecast 2013over 13 years ago
Product Liability Claims and Comment Kover 13 years ago
The Force Behind Sales Forcesover 13 years ago
The Scoop on Drug Shortagesover 13 years ago
Country Report: Singaporeover 13 years ago
Compliance in the C-Suiteover 13 years ago
Who Lost Syria?over 13 years ago
The Long Swim—Upstreamover 13 years ago
The Permanent Campaignover 13 years ago
Transformation to Characterize 2013Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5